{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:13:53Z","timestamp":1792030433056,"version":"4.4.0"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Despite notable advancements in cardiovascular medicine, morbidity and mortality rates associated with myocardial infarction (MI) remain high. The unfavourable prognosis and absence of robust post-MI protocols necessitate further intervention. In this comprehensive review, we will focus on well-established and novel biomarkers that can provide insight into the processes that occur after an ischemic event. More precisely, during the follow-up, it is of particular importance to monitor biomarkers that indicate an increase in myocardial stretch and stress, damage and death of cardiomyocytes, remodelling of the extracellular matrix, oxidative stress, and inflammation. This enables the identification of abnormalities in a timely manner, as well as the capacity to respond promptly to any changes. Therefore, we would like to highlight the importance of well-known markers, such as natriuretic peptides, high-sensitivity troponins, soluble suppression of tumorigenicity 2, galactin-3, C-reactive protein, and interleukins in post-MI settings, as well as biomarkers such as adrenomedullin, growth differentiation factor-15, insulin-like growth factor binding protein 7, amyloid beta, vitamin D, trimethylamine N-oxide, and advanced glycation end-products that recently emerged in the cardiovascular filed. The implementation of novel post-MI protocols, which encompass the monitoring of the aforementioned biomarkers deemed pertinent, in conjunction with adherence to established cardiac rehabilitation programmes, along with the already well-established therapeutic strategies and control of cardiovascular risk factors, has the potential to markedly enhance patient outcomes and reduce the elevated level of morbidity and mortality.<\/jats:p>","DOI":"10.3390\/jcm14010129","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:00:37Z","timestamp":1735628437000},"page":"129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biomarkers of Importance in Monitoring Heart Condition After Acute Myocardial Infarction"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-9905","authenticated-orcid":false,"given":"Aneta","family":"Aleksova","sequence":"first","affiliation":[{"name":"Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34100 Trieste, Italy"},{"name":"Department of Medical Surgical and Health Sciences, University of Trieste, 34125 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-8093","authenticated-orcid":false,"given":"Alessandra Lucia","family":"Fluca","sequence":"additional","affiliation":[{"name":"Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34100 Trieste, Italy"},{"name":"Department of Medical Surgical and Health Sciences, University of Trieste, 34125 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-2710","authenticated-orcid":false,"given":"Antonio Paolo","family":"Beltrami","sequence":"additional","affiliation":[{"name":"Dipartimento di Area Medica (DAME), Istituto di Patologia Clinica, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-0780","authenticated-orcid":false,"given":"Elena","family":"Dozio","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-8478","authenticated-orcid":false,"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34100 Trieste, Italy"},{"name":"Department of Medical Surgical and Health Sciences, University of Trieste, 34125 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1888-3430","authenticated-orcid":false,"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[{"name":"Cardiology Department Crete, School of Medicine, Heraklion University General Hospital, University of Crete, 70013 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-1439","authenticated-orcid":false,"given":"Milijana","family":"Janjusevic","sequence":"additional","affiliation":[{"name":"Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34100 Trieste, Italy"},{"name":"Department of Medical Surgical and Health Sciences, University of Trieste, 34125 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Schon, C., Felismino, A., de Sa, J., Corte, R., Ribeiro, T., and Bruno, S. (2024). Efficacy of early cardiac rehabilitation after acute myocardial infarction: Randomized clinical trial protocol. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0300855"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2024). Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Casrdiology (ESC). Eur. Heart J. Acute Cardiovasc. Care, 45, 1145.","DOI":"10.1093\/eurheartj\/ehad870"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1177\/2047487316663873","article-title":"Challenges in secondary prevention after acute myocardial infarction: A call for action","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2340\/16501977-0254","article-title":"Effects of 6 months exercise training on ventricular remodelling and autonomic tone in patients with acute myocardial infarction and percutaneous coronary intervention","volume":"40","author":"Zheng","year":"2008","journal-title":"J. Rehabil. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.2147\/JMDH.S418803","article-title":"Barriers and Facilitators to Delivering Inpatient Cardiac Rehabilitation: A Scoping Review","volume":"16","author":"Wasilewski","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tilea, I., Varga, A., and Serban, R.C. (2021). Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050881"},{"key":"ref_7","unstructured":"FDA-NIH Biomarker Working Group (2016). BEST (Biomarkers, EndpointS, and Other Tools) Resource, Food and Drug Administration (US)."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1373\/clinchem.2012.184705","article-title":"The riddle of protein diagnostics: Future bleak or bright?","volume":"59","author":"Anderson","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1373\/clinchem.2016.259564","article-title":"Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure","volume":"63","author":"Ibrahim","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Geyer, P.E., Holdt, L.M., Teupser, D., and Mann, M. (2017). Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol., 13.","DOI":"10.15252\/msb.20156297"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100577","DOI":"10.1016\/j.mcpro.2023.100577","article-title":"MS-Based Proteomics of Body Fluids: The End of the Beginning","volume":"22","author":"Bader","year":"2023","journal-title":"Mol. Cell Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","article-title":"Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction","volume":"7","author":"Aimo","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1002\/ehf2.13595","article-title":"Biomarkers in the management of acute heart failure: State of the art and role in COVID-19 era","volume":"8","author":"Aleksova","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2018.08.052","article-title":"Left ventricular adverse remodeling after myocardial infarction and its association with vitamin D levels","volume":"277","author":"Padoan","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ehf2.13203","article-title":"Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and\/or diastolic dysfunction","volume":"8","author":"Huttin","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: Pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1373\/jalm.2017.023655","article-title":"Sandwich Immunoassay for Bioactive Plasma Adrenomedullin","volume":"2","author":"Weber","year":"2017","journal-title":"J. Appl. Lab. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Winter, L.M., Reinhardt, D., Schatter, A., Tissen, V., Wiora, H., Gerlach, D., Tontsch-Grunt, U., Colbatzky, F., Stierstorfer, B., and Yun, S.W. (2023). Molecular basis of GDF15 induction and suppression by drugs in cardiomyocytes and cancer cells toward precision medicine. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-38450-w"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12265-013-9522-8","article-title":"Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling","volume":"7","author":"Motiwala","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e005133","DOI":"10.1161\/CIRCHEARTFAILURE.118.005133","article-title":"IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure","volume":"11","author":"Januzzi","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2021.11.027","article-title":"Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin","volume":"79","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1373\/clinchem.2011.165795","article-title":"Analytical characteristics of high-sensitivity cardiac troponin assays","volume":"58","author":"Apple","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ejhf.2394","article-title":"Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial","volume":"24","author":"Ravassa","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R1250","DOI":"10.1152\/ajpregu.00227.2003","article-title":"C-reactive protein: A surrogate risk marker or mediator of atherothrombosis?","volume":"285","author":"Blake","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nishikimi, T., and Nakagawa, Y. (2022). B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor\/Neprilysin Inhibitor Era?. Biology, 11.","DOI":"10.3390\/biology11071034"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-Type Natriuretic Peptide During Treatment With Sacubitril\/Valsartan: The PARADIGM-HF Trial","volume":"73","author":"Myhre","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.123.321673","article-title":"Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System","volume":"132","author":"Balint","year":"2023","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/ehf2.14120","article-title":"Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence","volume":"9","author":"Bracun","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ejhf.3227","article-title":"Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kumar, S., Griffith, N., Walter, D., Swett, M., Raman, V., Vargas, J.D., Deb, B., Chou, J., Arafat, A., and Srichai, M.B. (2023). Characterization of Myocardial Injury With High-Sensitivity Troponin. Tex. Heart Inst. J., 50.","DOI":"10.14503\/THIJ-23-8108"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/187152911798347025","article-title":"Fibrosis, Enzymatic and Non-Enzymatic Cross-Links in Hypertensive Heart Disease","volume":"11","author":"Ciulla","year":"2011","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rodriguez, C., and Martinez-Gonzalez, J. (2019). The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling. Cells, 8.","DOI":"10.3390\/cells8121483"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e011444","DOI":"10.1161\/JAHA.118.011444","article-title":"Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes","volume":"8","author":"Zelniker","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.0000092184.43176.91","article-title":"Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue","volume":"108","author":"Jabs","year":"2003","journal-title":"Circulation"},{"key":"ref_38","first-page":"439","article-title":"High-sensitivity C-reactive protein: Clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","article-title":"Clinical efficacy of an automated high-sensitivity C-reactive protein assay","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: Patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e031786","DOI":"10.1161\/JAHA.123.031786","article-title":"Connecting the Dots: Inflammatory Burden and Outcomes in Heart Failure","volume":"12","author":"Golino","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jacc.2018.11.054","article-title":"The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure","volume":"73","author":"Diez","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1515\/cclm-2021-0377","article-title":"Pre-analytical considerations in biomarker research: Focus on cardiovascular disease","volume":"59","author":"Barallat","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108741","DOI":"10.1016\/j.isci.2023.108741","article-title":"Plasmon resonance biosensor for interleukin-1beta point-of-care determination: A tool for early periodontitis diagnosis","volume":"27","author":"Cennamo","year":"2024","journal-title":"iScience"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cardfail.2022.08.010","article-title":"Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure","volume":"29","author":"Hayek","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2015.01.013","article-title":"Amyloid beta and cardiovascular disease: Intriguing questions indeed","volume":"65","author":"Williams","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jacc.2014.12.035","article-title":"Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease","volume":"65","author":"Stamatelopoulos","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","first-page":"924","article-title":"Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure","volume":"70","author":"Barallat","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhao, Z., Lin, E., Zhao, W., Qian, X., Freire, D., Bilski, A.E., Cheng, A., Vempati, P., and Ho, L. (2013). Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer\u2019s disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065232"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehv015","article-title":"Neprilysin, cardiovascular, and Alzheimer\u2019s diseases: The therapeutic split?","volume":"36","author":"Vodovar","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1139\/H07-081","article-title":"Effects of exercise on brain function: Role of free radicals","volume":"32","author":"Radak","year":"2007","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_54","first-page":"959","article-title":"Physical activity and beta-amyloid pathology in Alzheimer\u2019s disease: A sound mind in a sound body","volume":"16","author":"Ebrahimi","year":"2017","journal-title":"EXCLI J."},{"key":"ref_55","first-page":"153","article-title":"Endothelial Nitric Oxide Synthase (eNOS) and the Cardiovascular System: In Physiology and in Disease States","volume":"15","author":"Tran","year":"2022","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1515\/cclm-2024-0391","article-title":"The role of functional vitamin D deficiency and low vitamin D reservoirs in relation to cardiovascular health and mortality","volume":"63","author":"Herrmann","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19450","DOI":"10.1074\/jbc.M113.467670","article-title":"Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein","volume":"288","author":"Chen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wimalawansa, S.J. (2019). Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology, 8.","DOI":"10.3390\/biology8020030"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"120193","DOI":"10.1016\/j.lfs.2021.120193","article-title":"The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases","volume":"289","author":"Janjusevic","year":"2022","journal-title":"Life Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijcard.2016.08.322","article-title":"U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction","volume":"223","author":"Aleksova","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2013-1333","article-title":"Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the US nationally representative NHANES","volume":"98","author":"Sempos","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.numecd.2024.02.007","article-title":"Persistence of vitamin D deficiency among Italian patients with acute myocardial infarction","volume":"34","author":"Aleksova","year":"2024","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Aleksova, A., Fluca, A.L., Stornaiuolo, M., Barbati, G., Pierri, A., Zwas, D.R., Santon, D., D\u2019Errico, S., Marketou, M., and Sinagra, G. (2024). Intra-hospital variation of gut microbiota product, trimethylamine N-oxide (TMAO), predicts future major adverse cardiovascular events after myocardial infarction. Hellenic J. Cardiol., in press.","DOI":"10.1016\/j.hjc.2024.05.007"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Pello Lazaro, A.M., Villelabeitia Jaureguizar, K., Franco Pelaez, J.A., Venegas-Rodriguez, A., Acena, A., Kallmeyer, A., Canovas, E., Gonzalez-Casaus, M.L., Tarin, N., and Cristobal, C. (2024). Cardiac Rehabilitation Increases Plasma Klotho Levels. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061664"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e10558","DOI":"10.1002\/jbm4.10558","article-title":"FGF23 and Vitamin D Metabolism","volume":"5","author":"Latic","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ckj\/sfaa100","article-title":"Klotho: A link between cardiovascular and non-cardiovascular mortality","volume":"13","author":"Lanzani","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2016.10.012","article-title":"Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease","volume":"254","author":"Lefrandt","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4239\/wjd.v14.i7.995","article-title":"Advanced glycation end product signaling and metabolic complications: Dietary approach","volume":"14","author":"Khan","year":"2023","journal-title":"World J. Diabetes"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Egana-Gorrono, L., Lopez-Diez, R., Yepuri, G., Ramirez, L.S., Reverdatto, S., Gugger, P.F., Shekhtman, A., Ramasamy, R., and Schmidt, A.M. (2020). Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00037"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Jensen, L.J., Flyvbjerg, A., and Bjerre, M. (2015). Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/815942"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Odrovicsn\u00e9-T\u00f3th, A., Thauerer, B., Stritzinger, B., Kullich, W., Salzer, A., Skoumal, M., and Steinecker-Frohnwieser, B. (2023). The Patient\u2019s Physiological Status at the Start Determines the Success of the Inpatient Cardiovascular Rehabilitation Program. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051735"},{"key":"ref_72","first-page":"e368","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Cao, Y.X., Li, S., Liu, H.H., Zhang, M., Guo, Y.L., Wu, N.Q., Zhu, C.G., Dong, Q., Sun, J., and Dou, K.F. (2022). Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.797297"},{"key":"ref_74","first-page":"100046","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases","volume":"9","author":"Moreira","year":"2021","journal-title":"Am. Heart J. Plus"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/1\/129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:41Z","timestamp":1760115341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/1\/129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14010129"],"URL":"https:\/\/doi.org\/10.3390\/jcm14010129","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,29]]}}}